XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
  AIDS
  Influenza
  MRSA
  Tuberculosis
  Shigella
  HCV
  SARS
  Ebola
  Dengue
  Malaria
  Pertussis
  Mumps
  Prion Diseases
  Small Pox
  Anthrax
  Leishmaniasis
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Influenza Channel
subscribe to Influenza newsletter

Latest Research : Infectious Diseases : Influenza

   DISCUSS   |   EMAIL   |   PRINT
SRL Ranbaxy offers a quicker bird flu diagnostic test
Feb 14, 2006, 19:55, Reviewed by: Dr. Priya Saxena

"A first of its kind, it is the only diagnostic test for bird flu that can be effectively employed for mass screening and gives accurate results within just one day vis--vis two to ten days, which other available tests take."

 
SRL Ranbaxy, a pathology laboratory network promoted by India's pharma major Ranbaxy Laboratories, Monday announced the launch of the first diagnostic test for bird flu that can give results in just a day.

"A first of its kind, it is the only diagnostic test for bird flu that can be effectively employed for mass screening and gives accurate results within just one day vis--vis two to ten days, which other available tests take," said SRL Ranbaxy in a statement.

SRL Ranbaxy has a network of 550 sample collection centres and serves around 2,000 hospitals across the country.

The recent outbreak of avian flu in migratory birds in China, Mongolia, Russia and Turkey has raised fears that the virus responsible could spread to India and other countries.

"India has not reported any case of avian flu in humans or birds. But we must prepare ourselves if it arrives in India one day and be prepared to respond adequately if we are to contain the disease before it gets out of control," said Janak Singh Bajwa, chief operating officer of SRL Ranbaxy.

"We are proud of this endeavour and this test will be available across our 550 centres in over 350 cities through our network."

These tests will cost between Rs.1,200-Rs.2,500 ($27-$56).
 

- Indo-Asian News Service
 

 
Subscribe to Influenza Newsletter
E-mail Address:

 



Related Influenza News

Are influenza vaccines worth the effort?
Oseltamivir significantly reduces the risk of death from influenza
Prisons Unprepared for Flu Pandemic
University of Pittsburgh receives $1.3 million grant for developing a promising avian flu vaccine
Novel DNA-Based H5N1(Avian) influenza vaccine
Genetic differences between potential pandemic influenza strains outlined
Avian flu virus needs only minor adaptations to infect humans
Influenza-Associated Hospitalization in a Subtropical City
SRL Ranbaxy offers a quicker bird flu diagnostic test
Bird flu vaccine may be fruitless


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us